Overcoming biopharma's trust deficit
Why people mistrust the biopharma industry--and what to do about it
Consumers may appreciate pharma companies’ efforts to speed up the process of bringing COVID-19 vaccines to market. How might biopharma continue to innovate while building trust?
The future unmasked
Predicting the future of healthcare and life sciences in 2025
What does the future hold for the life sciences and healthcare industry? Our latest predictions report looks ahead to the year 2025 to help you see what’s coming and to keep your organisation moving forward.
Securing trust in the global COVID-19 supply chain
From development and delivery to acceptance and administration
COVID-19 vaccines and therapeutics, and the associated medical devices and consumables, present an urgent need for a protected supply chain and a system of traceability built around globally identified products.
The impact of COVID-19 on medical schemes
The Impact of COVID-19 on Medical Schemes The South African health care system and global healthcare systems have recently come under additional pressures following the outbreak of the Corona (COVID-19) pandemic.
Findings from the Deloitte 2019 Health Care CEO Perspectives Study
Accelerating change is now a basic feature of the health care industry. Deloitte’s discussions with CEOs across the industry offer insights into drivers of change, priorities, and worries, and how the definition of success is evolving.